CBLI - クリ―ブランド・バイオラブ (Cleveland BioLabs Inc.)

CBLIのニュース

   Cleveland BioLabs reports Q2 results  2021/08/16 11:46:40 Seeking Alpha
   Cleveland BioLabs secures $90M in debt and equity financing  2021/07/29 16:01:40 Seeking Alpha
   Cytocom Inc. Announces Completed Merger with Cleveland BioLabs  2021/07/28 12:30:00 PR Newswire
FORT COLLINS, Colo., July 28, 2021 /PRNewswire/ -- Cytocom Inc. ("Cytocom" or "Company"), a leading biopharmaceutical company creating next-generation therapies that focus on immune homeostasis, today announced the completion of its merger with Cleveland BioLabs, Inc. The all-stock
   Earnings Report: Heres what to expect from Cleveland BioLabs (NASDAQ:CBLI)  2021/07/02 13:20:00 Stock Market Daily
Earnings results for Cleveland BioLabs , Analyst Opinion on Cleveland BioLabs , Earnings and Valuation of (NASDAQ:CBLI), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Earnings Report: Heres what to expect from Cleveland BioLabs (NASDAQ:CBLI) appeared first on .
   CBLI liquidators lose ground with frivolous PwC suit  2021/06/18 03:54:12 National Business Review
CBLI liquidators lose ground with frivolous PwC suit reweti 18 Jun 21
   Earnings Report: Heres what to expect from Cleveland BioLabs (NASDAQ:CBLI)  2021/07/02 13:20:00 Stock Market Daily
Earnings results for Cleveland BioLabs , Analyst Opinion on Cleveland BioLabs , Earnings and Valuation of (NASDAQ:CBLI), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Earnings Report: Heres what to expect from Cleveland BioLabs (NASDAQ:CBLI) appeared first on .
   CBLI liquidators lose ground with frivolous PwC suit  2021/06/18 03:54:12 National Business Review
CBLI liquidators lose ground with frivolous PwC suit reweti 18 Jun 21
   Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC  2021/06/17 22:37:00 Finanzen CH
FORT COLLINS, Colo. and BUFFALO, N.Y., June 17, 2021 /PRNewswire/ -- Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate the immune system, announced that its
   Is Cleveland BioLabs, Inc. (CBLI) A Good Stock To Buy Now?  2021/06/15 18:14:27 Insider Monkey
   How Have the Numbers Shaped Up for Cleveland BioLabs (NASDAQ:CBLI)  2021/06/11 14:15:00 Stock Market Daily
Earnings results for Cleveland BioLabs , Analyst Opinion on Cleveland BioLabs , Earnings and Valuation of (NASDAQ:CBLI), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post How Have the Numbers Shaped Up for Cleveland BioLabs (NASDAQ:CBLI) appeared first on .
   SHAREHOLDER ALERT: WeissLaw LLP Reminds TLRY, CBLI, AKER and OBLN Shareholders About Its Ongoing Investigations  2021/03/19 19:42:00 PR Newswire
NEW YORK, March 19, 2021 /PRNewswire/ -- Tilray, Inc. (NASDAQ: TLRY) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tilray, Inc. (NASDAQ: TLRY) in connection with the company's proposed merger with Aphria Inc….
   SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations  2021/03/12 20:31:00 Benzinga
NEW YORK , March 12, 2021 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: CONTACT: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor New York , NY 10036 (212) 682-3025 (888) 593-4771 Full story available on Benzinga.com
   Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock - Stocks News Feed  2021/02/19 18:38:38 Stocks News Feed
BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.00 per share in a registered direct offering. The closing… Read More »Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
   Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock  2021/02/19 18:30:00 Yahoo Finance
BUFFALO, NY / ACCESSWIRE / February 19, 2021 / Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has entered into definitive agreements with certain healthcare-focused and institutional investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.
   The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout  2021/02/18 13:14:37 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17) Advaxis, Inc. (NASDAQ: ADXS ) Angion Biomedica Corp (NASDAQ: ANGN ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Avanos Medical Inc (NYSE: AVNS ) Bausch Health Companies Inc (NYSE: BHC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bioatla Inc (NASDAQ: BCAB ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Chimerix Inc (NASDAQ: CMRX ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Endo International PLC (NASDAQ: ENDP ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Lucira Health Inc (NASDAQ: LHDX ) Nektar Therapeutics (NASDAQ: NKTR ) (announced a $150-million investment by SFJ Pharma for the Phase 2/3 registrational clinical study of BEMPEG plus Keytruda in patients with head and neck cancer) Oncolytics Biotech, Inc. (NASDAQ: ONCY ) (reacted to initiation of coverage by H.C.

calendar